The Annexure

News to 27 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 27 October 2026

Change in Directorate

Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company.

The filing

Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company.

Company
Onesource Specialty Pharma Ltd · BSE 544292
Filed
27 October 2026, 10:13 IST
BSE category
Company Update / Change in Directorate
Tag
Change in Directorate · selected
Source
Open the filing on BSE →

Why it led

  • Small cap · NIFTY 500
  • 3 filings today

Selected by the ranker from 11 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

813 of 84,871 filings in the published window carry Change in Directorate · 0.96%

Around it

Also filed by Onesource Specialty Pharma Ltd on 27 October 2026

Most recent filings from Onesource Specialty Pharma Ltd

The company

Onesource Specialty Pharma Ltd

BSE 544292 · NSE ONESOURCE · ISIN INE013P01021 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Full figures, price and filing history for Onesource Specialty Pharma Ltd →